Some matrine derivatives can also inhibit the proliferation of hepatocellular carcinoma (HCC) cells through the PI3K/AKT/mTOR and AKT/GSK3/β-catenin signaling pathway [138]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.